Titolo	Autore(i)	Anno	Periodico	Editore	Tipo
1	Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.	Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.	2010	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA		1.01 Articolo in rivista
2	We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction.	Bernengo MG;Santucci M;Zinzani PL	2012	GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA		1.04 Replica / breve intervento (e simili)
3	VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.	Fina M; Tani M; Stefoni V; Musuraca G; Marchi E; Pellegrini C; Alinari L; Derenzini E; Bacci F; Pileri S; Baccarani M; Zinzani PL.	2007	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
4	Vemurafenib mucosal side-effect.	A. Pileri;M. Cricca;L. Gandolfi;C. Misciali;B. Casadei;P. L. Zinzani;A. Patrizi	2016	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY		1.01 Articolo in rivista
5	Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified.	Piccaluga P.P.; Agostinelli C.; Gazzola A.; Sista M.T.; Righi S.; Bacci F.; Sabattini E.; Rossi M.; Mannu C.; Went P.; Zinzani P.L.; Pileri S.A.	2010		s.n	4.02 Riassunto (Abstract)
6	Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.	Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Baccarani M; Zinzani PL	2005	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
7	Utility of baseline 18FDG PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma	L. Ceriani;M. Martelli;P. L. Zinzani;A. J. M;B. Botto;C. Stelitano;M. Gotti;M. G. Cabras;L. Rigacci;L. Gargantini;F. Merli;G. Pinotti;D. Mannina;S. Luminari;A. Stathis;E. Russo;F. Cavalli;L. Giovanella;P. W. M;E. Zucca	2015	BLOOD		1.01 Articolo in rivista
8	The unique biology and treatment of primary mediastinal B-cell lymphoma	Broccoli, Alessandro; Zinzani, Pier Luigi	2018	BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY		1.01 Articolo in rivista
9	Understanding the group of peripheral T-cell lymphomas, unspecified.	Zucca E.; Zinzani PL.	2005	CURRENT HEMATOLOGY REPORTS		1.01 Articolo in rivista
10	The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients	Broccoli, Alessandro; Casadei, Beatrice; Stefoni, Vittorio; Pellegrini, Cinzia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Marangon, Miriam; Argnani, Lisa; Zinzani, Pier Luigi	2017	BMC CANCER		1.01 Articolo in rivista
11	Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations	Dreyling, Martin; Aurer, Igor; Cortelazzo, Sergio; Hermine, Olivier; Hess, Georg; Jerkeman, Mats; Le Gouill, Steven; Ribrag, Vincent; Trněný, Marek; Visco, Carlo; Walewski, Jan; Zaja, Francesco; Zinzani, Pier Luigi	2018	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
12	Tissue micro-array in haematopathology:present usage and potential.	Pileri S.; Agostinelli C.; Campidelli C.; Righi S.; Piccioli M.; Bacci F.; Sabattini E.; Zinzani P.L.; Piccaluga P.P.	2006	HAEMATOLOGICA		4.01 Contributo in Atti di convegno
13	Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.	Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani, P L; Bernengo MG; On behalf of the Gruppo Italiano Linfomi Cutanei (GILC).	2012	CANCER		1.01 Articolo in rivista
14	Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma.	Zinzani PL.	2006	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
15	Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.	B. Coiffier;M. Federico;D. Caballero;C. Dearden;F. Morschhauser;U. Jäger;L. Trümper;E. Zucca;M. G. da;R. Pettengell;E. Weidmann;F. d'Amore;H. Tilly;P. L. Zinzani	2014	CANCER TREATMENT REVIEWS		1.01 Articolo in rivista
16	Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma	Derenzini, Enrico; Iacobucci, Ilaria; Agostinelli, Claudio; Imbrogno, Enrica; Storlazzi, Clelia Tiziana; L`abbate, Alberto; Casadei, Beatrice; Ferrari, Anna; GHELLI LUSERNA DI RORÀ, Andrea; Martinelli, Giovanni; Pileri, Stefano; Zinzani, PIER LUIGI	2015	EXPERIMENTAL HEMATOLOGY & ONCOLOGY		1.01 Articolo in rivista
17	The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.	Luminari S;Biasoli I;Arcaini L;Versari A;Rusconi C;Merli F;Spina M;Ferreri AJ;Zinzani PL;Gallamini A;Mastronardi S;Boccomini C;Gaidano G;D'Arco AM;Di Raimondo F;Carella AM;Santoro A;Musto P;Federico M	2013	ANNALS OF ONCOLOGY		1.01 Articolo in rivista
18	The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma	Derenzini E; Iacobucci I; Brighenti E; Cattina F; Davis RE; Pileri S; Martinelli G; Baccarani M; Zinzani PL	2011	BLOOD		4.02 Riassunto (Abstract)
19	The role of surgery for haematologic neoplasms of bone.	Mavrogenis A.F.; Angelini A.; Pala E.; Zinzani P.; Ruggieri P.	2012	ACTA ORTHOPAEDICA BELGICA		1.01 Articolo in rivista
20	The role of mitoxantrone in the treatment of indolent lymphomas.	HAGEMEISTER F; CABANILLAS F; COLEMAN M; GREGORY SA; ZINZANI P.	2005	ONCOLOGY		1.01 Articolo in rivista